ADNP Kids Research Foundation
  • About
    • What is ADNP
    • Our Story
    • Our Mission
    • Our Team
    • Medical and Scientific Advisory Board
    • 501(c)(3) Determination
    • Inclusivity Statement
  • RESEARCH
    • Research Projects
    • Research Strategy
    • Ketamine Trial
    • Ketamine Trial Publication
    • Ketamine Update
    • Path to a cure
    • NET STUDY
    • publications
  • Families
    • Newly Diagnosed
    • ADNP Patient Registry
    • Contact Registry
    • Understanding the Basics
    • Worldwide Parent Ambassadors
    • contact us
    • ADNP Family Conference >
      • HIGHLIGHTS- ADNP Syndrome Family Conference
      • TSA Travel Help
      • #CureADNP
  • NEWS
    • NET Collaboration Study
    • Ketamine Trial Phase 2 Announcement
    • Mount Sinai Launches First Drug Trial for ADNP Syndrome
    • Seaver Midtown Partnership
    • Biomarker Discovered
    • NEWS - p.Tyr719* Case Study
    • NEWS HIGHLIGHTS- ADNP Syndrome Family Conference
  • ADNP STORE
  • DONATE/SUPPORT
    • Warrior Fun Run 2022 >
      • Past Fun Run Pictures
      • Sponsorship Opportunity
    • Boston Marathon
    • Third Party Fundraising
  • About Us new

Research

ADNP Kids Research Foundation
​is the largest funder

​of ADNP syndrome research in the world.
The ADNP Kids Research Foundation aims to ensure this devastating conditions receives the research attention and funding it requires and deserves.
Picture
Our Research Strategy

​ADNP Kids Research Foundation has developed a research strategy that aims to maximize the impact of the funds we invest, and identifies research areas that provide the greatest scientific advances toward treatments, a cure and the most relevance for our families
. 
​The ADNP Kids Research Foundation is funding science to understand the biology of ADNP and identify innovative therapeutic strategies and a cure for all individuals around the world with ADNP syndrome.   
  • NOTE:  We are a 100% volunteer-ran patient organization, we do not pay university overhead fees as part of our grants or sponsorships.  If you are interested in discussing a grant opportunity please email admin@adnpfoundation.org.
Roadman to a Cure
The ADNP Kids Research Foundation's Roadmap is focused on elements supporting therapeutic approaches that have the potential to treat and cure the effects of the disorder in children, teens and adults. 

Gene Therapy / Gene Replacement Approaches
ADNP Kids Research Foundation is funding research in gene/protein replacement and gene therapy approaches that are focused on increasing ADNP expression. 

Gene/protein replacement therapy delivers healthy copies of the ADNP gene or protein to compensate for the haploinsufficiency of the mutated or deleted ADNP gene.  Treatment is delivered via a viral vector called Adeno-Associated Virus (AAV) technology.  

Gene therapies and antisense oligonucleotide therapies (ASOs) are Antisense oligonucleotide therapies and epigenetic gene editing are therapeutic platforms that we are also exploring.

The ADNP Kids Research Foundation has created a gene therapy program that will evaluate multiple gene therapies simultaneously through 2024.

Downstream or Symptomatic Therapy Approaches
Downstream therapy includes drugs that treat the symptoms of ADNP syndrome like sleep, behaviors, seizures, etc.  There are many drugs that are already approved by the FDA that might be useful for treating ADNP syndrome, but are not labelled for ADNP syndrome.  Finding these drugs and showing that they can be repurposed can help to bring new treatments to ADNP syndrome.  We are currently using high throughput screening platforms and drug investigation programs to find already existing and new small molecules that may be therapeutic for ADNP syndrome.  

Therapeutics being targeted often improve function of ADNP symptoms and therefor quality of life.  Different strategies are being pursued including repurposed drugs as well as novel compounds or peptides.

Supporting Assets
As we prepare for clinical trials, there are many important things that must be supported.

Creating animal models and cell lines is important to ensure that we know how drugs can behave and improve symptoms.  ADNP Kids Research Foundation has funded the creation of mouse models, including behavioral characterization by the best in world in this field.

ADNP Kids Research Foundation has also created a Global Patient Registry and Global Contact Registry, and will begin the ADNP Natural History studies soon, to collect key data from those living with ADNP syndrome to understand the impact ADNP has on things like communication, sleep, autism/behavior, gross/fine motor skills and seizures.  This data is used to inform research and trails so that we can ensure meaningful change can be measured with effective therapeutics.
  
OUR RESEARCH DATA
Data from the ADNP Kids Research Foundation Contact and Patient Registries show the following mutations.  There are approximatly 200 more patients who have gone through our group site but have not registered, totalling an estimated 475 patients.
x​ p.K274NfsX311
20q13.13q12.2DELETION…...TOTAL…...(14)
c.1A>Gp.Met1…...TOTAL…...(1)
c.2T>Cp.? Q87.8…...TOTAL…...(1)
c.68T>Cp.(Leu23Pro)…...TOTAL…...(2)
c.14delCp.Pro5Leufs*8…...TOTAL…...(1)
c.56_57delTGp.V19EfsX5…...TOTAL…...(10)
c.64dupAlle22AsnfsTer3…...TOTAL…...(1)
c.79G>Ap.G27R…...TOTAL…...(1)
c.82_85delTTGGp.L28NfsX7…...TOTAL…...(1)
c.104_105del(I35Rfs*4)…...TOTAL…...(1)
c.106_107dup Asp37fs …...TOTAL…...(2)
c.118C>Tp.Q40X…...TOTAL…...(1)
c.138_139delp.Phe46Leufs*52…...TOTAL…...(1)
c.165delTp.Asp55fs…...TOTAL…...(1)
c.182dupC…...TOTAL…...(1)
c.201G>Cp.Q67H…...TOTAL…...(1)
c.202-5_202-del…...TOTAL…...(1)
c.216p.Arg216Ter…...TOTAL…...(1)
c.222dupTp.Phe742LeufsTer2…...TOTAL…...(1)
c.252delAp.Lys84AsnfsX77…...TOTAL…...(1)
c.284A>Gp.Asn95Ser…...TOTAL…...(1)
c.319delCp.Leu107fs…...TOTAL…...(1)
c.361_362 delL121 fs…...TOTAL…...(1)
c.362T>ALeu121…...TOTAL…...(1)
c.372_373delp.lle125*…...TOTAL…...(2)
c.399delCp.Ser134ala*27…...TOTAL…...(1)
c.405dupp.Pro136Thrfs*3…...TOTAL…...(1)
c.424dupp.Thr142Asnfs*5…...TOTAL…...(1)
c.454_466del13P.Leu152ArgfsX5…...TOTAL…...(1)
c.484C>Tp.Q162X…...TOTAL…...(1)
c.516>Ap.Tyr172*…...TOTAL…...(1)
c.517C>Tp.R173X…...TOTAL…...(1)
c.529T>Cp.Y177H…...TOTAL…...(1)
c.532dupp.Glu178Glyfs*4…...TOTAL…...(1)
c.539_542deITTAGp.(Val180Glyfs*17)…...TOTAL…...(1)
c.568C>Tp.Gln190Ter…...TOTAL…...(2)
c.593_542delP.Val180Glyfs*17…...TOTAL…...(1)
c.607A>Gp.K203E…...TOTAL…...(1)
c.609dupSer204llefs*17…...TOTAL…...(2)
c.613_616delL205Mfs*6…...TOTAL…...(3)
c.622dupp.Ala208Glyfs*13…...TOTAL…...(1)
c.673C>Tp.(Arg225Ter)…...TOTAL…...(2)
c.790C>Tp.Arg264*…...TOTAL…...(3)
c.819_820inTp.K274X…...TOTAL…...(1)
c.838_839delAGp.Ser280Hisfs*33…...TOTAL…...(1)
c.853_857delCCAAGp.Pro285AspfsX27…...TOTAL…...(1)
c.916C>Tp.Arg306Ter…...TOTAL…...(2)
c.922_923delp. S308Nfs*5…...TOTAL…...(1)
c.940_941delTTp.L314KfsX84…...TOTAL…...(1)
c.1035_1038delGTCAp.S346X…...TOTAL…...(2)
c.1046_1047delTGL349RfsX49…...TOTAL…...(1)
c.1102C>Tp.Gln368Ter…...TOTAL…...(2)
c.1106_1108delTACinsCTGTp.L369SfsXS30…...TOTAL…...(1)
c.1117G>T (Gly373*)20q13…...TOTAL…...(1)
c.1150C>Tp.(Gln384*)…...TOTAL…...(1)
c.1207_1208delTCp.Ser403IlefsX36…...TOTAL…...(1)
c.1211C>Ap.Ser404*…...TOTAL…...(2)
c.1222_1223delp.Lys408Valfs*31…...TOTAL…...(2)
c.1240_1241delp.Gln414ValfsTer25…...TOTAL…...(2)
c.1313delGp.G438VfsX40…...TOTAL…...(1)
c.1328_1332delTTAAp.Thr443Lysfs*9…...TOTAL…...(1)
c.1337G>ATrp446*…...TOTAL…...(1)
c.1365_*33delp.456Phe_1102Ala Del/Dup…...TOTAL…...(1)
c.1490A>GTyr497Cys…...TOTAL…...(1)
c.1534_1535dupCTp.Ser513CysfsTer37…...TOTAL…...(1)
c.1562_1571del10p.F521WfsX25…...TOTAL…...(1)
c.1633_1643p.Asp545Phefs*6…...TOTAL…...(1)
c.1707C>Ap.Tyr569Ter…...TOTAL…...(2)
c.1792C>Tp.Q598X…...TOTAL…...(1)
C.1807_1808dupP.pro604serfster3…...TOTAL…...(1)
c.1855G>Tp.V619F…...TOTAL…...(2)
c.1876_1892del17p.L626KfsX6…...TOTAL…...(1)
c.190dupAp.T64NfsX35…...TOTAL…...(2)
c.1922A>Gp.His641Arg…...TOTAL…...(1)
c.1929dupp.(R644Tfs*14)…...TOTAL…...(1)
c.2000G>Ap.C667Y…...TOTAL…...(1)
c.2130delAinsCA / c.2129dupCp.Ser711LysfsTer24…...TOTAL…...(1)
c.2156_2157insAp.Tyr719*…...TOTAL…...(2)
c.2156dupp.Tyr719*…...TOTAL…...(8)
c.2156dupAp.Tyr719*…...TOTAL…...(8)
c.2157C>Ap.Tyr719*…...TOTAL…...(7)
c.2157C>Gp.Tyr719*…...TOTAL…...(32)
c.2157C>Tp. Tyr719*…...TOTAL…...(1)
c.2157delCp.Tyr719*…...TOTAL…...(1)
c.2158G>TGlu720Ter…...TOTAL…...(1)
c.2161C>Tp.Gin721*…...TOTAL…...(1)
c.2167delGp.(Glu723Asnfs*5)…...TOTAL…...(1)
c.2175delCp.Leu726TyrfsX2…...TOTAL…...(1)
c.2184_2188delArg730fs…...TOTAL…...(1)
c.2187dupAp.R730TfsX5…...TOTAL…...(2)
c.2188C>Tp.Arg730*…...TOTAL…...(22)
c.2189delGp.Arg730G1nfs*2…...TOTAL…...(1)
c.2194_2197delTTAGp.L732MfsX20…...TOTAL…...(3)
c.2195T>Gp.Leu732*  …...TOTAL…...(1)
c.2212dupTp.Ser738Phefs*6…...TOTAL…...(1)
c.2213C>Ap.S738X…...TOTAL…...(8)
c.2229delp.Glu744argfs*9…...TOTAL…...(1)
c.2230G>Tp.E744X…...TOTAL…...(2)
C.2239G>TP.e747x…...TOTAL…...(1)
c.2250_2274delp.V751fs…...TOTAL…...(1)
c.2251delGinsTAAAp.Val751*…...TOTAL…...(1)
c.2268dupCp.K757QfsX4…...TOTAL…...(1)
c.2287delTp.Ser763ProfsX9…...TOTAL…...(3)
c.2318delp.Lys773SerfsTer17…...TOTAL…...(1)
c.2340T>GP.Tyr780*…...TOTAL…...(1)
c.2355_2356delAAp.Glu785AspfsTer2…...TOTAL…...(1)
c.2419_2423delAAAAGp.Lys807Glufs*6…...TOTAL…...(2)
c.2424_2427delGAAG / TCTTC>Tp. Lys809Serfs*19…...TOTAL…...(1)
c.2491 2494 del TTAAp.(Leu831fsTer81)…...TOTAL…...(7)
c.2495_2499delp.Asn832Lyfsf*81…...TOTAL…...(1)
c.2496_2499delp.Asn832LysfsTer81…...TOTAL…...(17)
c.2630_2633delACAGp.Asp877VaifsX36…...TOTAL…...(1)
c.2707_2710delTTAALeu903IlefsTer82…...TOTAL…...(1)
c.2865_2868delP.(S955Rfs*36)…...TOTAL…...(1)
c.2866_2868delp.Ser955Argfs*36…...TOTAL…...(1)
c.2971_2979delp.MET991_Pro993del…...TOTAL…...(2)
c.3071_3072delGlu1024Alafs*7…...TOTAL…...(1)
c.3077_3078insATTTP.(lys1027phefs*6)…...TOTAL…...(1)
c.3248dupGp.V1084AfsX3…...TOTAL…...(1)
c.3293G>Ap.Ser1098Asn …...TOTAL…...(1)
chr20:50.892.214 - 50.892.218p.Asn832Lysfs*81 ENST00000349014…...TOTAL…...(1)
Chr20:50.892.382 G>Ap.Gen778*ENST00000349014…...TOTAL…...(1)
T2322GY774X…...TOTAL…...(1)
Picture
Privacy Policy  |  Terms of Services  |  Other Policies  
All rights reserved. No portion of the content of this website may be reproduced in any manner without the written permission of the author/creator.   Any information used from this website must also have credit noted to ADNP Kids Research Foundation / www.adnpfoundation.org.
Disclosure: This page represents information known to the best of our knowledge.  Given the sensitivity and fast changing pace of research and drug development, some of the information posted on our website www.adnpfoundation.org may be inaccurate or not complete, therefor this information should be confirmed by the reader. Additionally, the medical information on this website is not substitute for personal diagnosis or medical care advise. Families and patients should consult a medically qualified clinician in all matters relating to genetic diagnosis, disease management and health. Information on ADNP research is a very fast-moving field and while the information here is believed to be the best available at the time of publication, some facts may later be updated or change. Please see additional disclosures on our PRIVACY POLICY page.
  • About
    • What is ADNP
    • Our Story
    • Our Mission
    • Our Team
    • Medical and Scientific Advisory Board
    • 501(c)(3) Determination
    • Inclusivity Statement
  • RESEARCH
    • Research Projects
    • Research Strategy
    • Ketamine Trial
    • Ketamine Trial Publication
    • Ketamine Update
    • Path to a cure
    • NET STUDY
    • publications
  • Families
    • Newly Diagnosed
    • ADNP Patient Registry
    • Contact Registry
    • Understanding the Basics
    • Worldwide Parent Ambassadors
    • contact us
    • ADNP Family Conference >
      • HIGHLIGHTS- ADNP Syndrome Family Conference
      • TSA Travel Help
      • #CureADNP
  • NEWS
    • NET Collaboration Study
    • Ketamine Trial Phase 2 Announcement
    • Mount Sinai Launches First Drug Trial for ADNP Syndrome
    • Seaver Midtown Partnership
    • Biomarker Discovered
    • NEWS - p.Tyr719* Case Study
    • NEWS HIGHLIGHTS- ADNP Syndrome Family Conference
  • ADNP STORE
  • DONATE/SUPPORT
    • Warrior Fun Run 2022 >
      • Past Fun Run Pictures
      • Sponsorship Opportunity
    • Boston Marathon
    • Third Party Fundraising
  • About Us new